Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Laurini

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
ACS Applied Materials & Interfaces|December 14, 2016
Mix and Match: Coassembly of Amphiphilic Dendrimers and Phospholipids Creates Robust, Modular, and Controllable InterfacesSamuel S Hinman, Charles J Ruiz, Yu Cao, et al.
European Journal of Medicinal Chemistry|April 26, 2021
Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ<sub>1</sub> receptor affinity, antitumor and analgesic activityNicole Kopp, Gianluca Civenni, Domenico Marson, et al.
Oncotarget|September 17, 2017
Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant ImatinibVittorio Perfetti, Erik Laurini, Suzana Aulić, et al.
Biomaterials Science|July 3, 2019
Self-assembled multivalent (SAMul) ligand systems with enhanced stability in the presence of human serumMarta Tena-Solsona, Domenico Marson, Ana C Rodrigo, et al.
International Journal of Cancer|May 18, 2010
Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling studyPalma Dileo, Sabrina Pricl, Elena Tamborini, et al.
Organic Letters|August 31, 2013
Structural requirements of 2-oxoglutaric acid analogues to mimic its signaling functionXinjun Liu, Yang Wang, Erik Laurini, et al.
European Journal of Medicinal Chemistry|November 5, 2020
Novel σ<sub>1</sub> antagonists designed for tumor therapy: Structure - activity relationships of aminoethyl substituted cyclohexanesNicole Kopp, Catharina Holtschulte, Frederik Börgel, et al.
Nanomedicine (London, England)|August 29, 2019
Efficient and innocuous delivery of small interfering RNA to microglia using an amphiphilic dendrimer nanovectorAleksandra Ellert-Miklaszewska, Natalia Ochocka, Marta Maleszewska, et al.
Nanoscale|June 1, 2022
Dynamic self-assembling supramolecular dendrimer nanosystems as potent antibacterial candidates against drug-resistant bacteria and biofilmsDinesh Dhumal, Bar Maron, Einav Malach, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cellsDavide Genini, Lara Brambilla, Erik Laurini, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
ACS Applied Materials & Interfaces|December 14, 2016
Mix and Match: Coassembly of Amphiphilic Dendrimers and Phospholipids Creates Robust, Modular, and Controllable InterfacesSamuel S Hinman, Charles J Ruiz, Yu Cao, et al.
European Journal of Medicinal Chemistry|April 26, 2021
Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ<sub>1</sub> receptor affinity, antitumor and analgesic activityNicole Kopp, Gianluca Civenni, Domenico Marson, et al.
Oncotarget|September 17, 2017
Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant ImatinibVittorio Perfetti, Erik Laurini, Suzana Aulić, et al.
Biomaterials Science|July 3, 2019
Self-assembled multivalent (SAMul) ligand systems with enhanced stability in the presence of human serumMarta Tena-Solsona, Domenico Marson, Ana C Rodrigo, et al.
International Journal of Cancer|May 18, 2010
Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling studyPalma Dileo, Sabrina Pricl, Elena Tamborini, et al.
Organic Letters|August 31, 2013
Structural requirements of 2-oxoglutaric acid analogues to mimic its signaling functionXinjun Liu, Yang Wang, Erik Laurini, et al.
European Journal of Medicinal Chemistry|November 5, 2020
Novel σ<sub>1</sub> antagonists designed for tumor therapy: Structure - activity relationships of aminoethyl substituted cyclohexanesNicole Kopp, Catharina Holtschulte, Frederik Börgel, et al.
Nanomedicine (London, England)|August 29, 2019
Efficient and innocuous delivery of small interfering RNA to microglia using an amphiphilic dendrimer nanovectorAleksandra Ellert-Miklaszewska, Natalia Ochocka, Marta Maleszewska, et al.
Nanoscale|June 1, 2022
Dynamic self-assembling supramolecular dendrimer nanosystems as potent antibacterial candidates against drug-resistant bacteria and biofilmsDinesh Dhumal, Bar Maron, Einav Malach, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cellsDavide Genini, Lara Brambilla, Erik Laurini, et al.
Pageof 12